Illumina
Philips and Illumina partner up for integrated genomics oncology solution
January 11, 2017Research and Development Illumina, Philips, oncology
Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …
Illumina shares plunge as it cuts Q1 outlook
April 20, 2016Research and Development, Sales and Marketing Financial, Illumina, Share price, Shares, outlook, revenue, stock market
Shares in Illumina (Nasdaq: ILMN) plunged after the company cut its revenue estimates for the first quarter based on low …
Illumina forms spin-off to develop cancer detection test
January 14, 2016Research and Development Cancer, Illumina, cancer detection, gene sequencing, liquid biospy, oncology
Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …
Merck Serono bets on precision medicine
March 11, 2015Sales and Marketing AstraZeneca, Diagnostics, FDA, Illumina, Merck Serono, opexa, personalised
Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …
Genentech and Human Longevity ink genomics deal
January 19, 2015Research and Development, Sales and Marketing 23andME, DNA, Genentech, Illumina, hli, human longevity
Genentech is partnering with US genetics firm Human Longevity (HLI) in another 2015 genomics deal to continue its push into …
AstraZeneca and Illumina in new partnership
August 26, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Illumina, NGS technology, next generation sequencing
AstraZeneca has announced that it will develop next generation sequencing (NGS) for companion diagnostic tests in a new partnership with …
Roche pays $8.3bn for InterMune
August 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche
Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …
Genomes Project gains £300m UK funding boost
August 1, 2014Medical Communications, Research and Development, Sales and Marketing Genomics england, Illumina, NHS England, david cameron, genomes
A new funding stream aimed at helping British scientists map human DNA code will ‘revolutionise medicine’, according to prime minister …
Roche earmarks $300m for diagnostics HQ
June 26, 2012Manufacturing and Production Diagnostics, Illumina, Roche, US, manufacturing
Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …
Roche abandons Illumina takeover bid
April 19, 2012Sales and Marketing Diagnostics, Illumina, Roche, mergers and acquisitions
Roche has conceded defeat in its bid to buy Illumina, after shareholders of the diagnostics firm blocked the takeover – …
Roche on target despite European shrinkage
April 12, 2012Sales and Marketing Illumina, Q1 2012, Roche
Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …
Roche launches $5.7 billion hostile bid for Illumina
January 25, 2012Research and Development, Sales and Marketing Diagnostics, Illumina, Roche
Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …
The utility of next generation sequencing in drug development
November 3, 2010Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing
Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …
